Cargando…

Attenuated ZHX3 expression serves as a potential biomarker that predicts poor clinical outcomes in breast cancer patients

BACKGROUND: The ZHX family has recently been in the spotlight as an integrator and an indispensable node in carcinogenesis, whose expression is frequently dysregulated in multiple cancers. The current study provides a novel investigation of the expression profiles of ZHX factors in breast cancer. MA...

Descripción completa

Detalles Bibliográficos
Autores principales:	You, Yanjie, Ma, Yuhong, Wang, Qiang, Ye, Zhengcai, Deng, Yanhong, Bai, Feihu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368119/ https://www.ncbi.nlm.nih.gov/pubmed/30787639 http://dx.doi.org/10.2147/CMAR.S184340

Ejemplares similares

Attenuated ZHX3 expression is predictive of poor outcome for liver cancer: Indication for personalized therapy
por: You, Yanjie, et al.
Publicado: (2022)

Zoledronic acid exhibits radio-sensitizing activity in human pancreatic cancer cells via inactivation of STAT3/NF-κB signaling
por: You, Yanjie, et al.
Publicado: (2019)

ZHX2 in health and disease
por: Li, Na, et al.
Publicado: (2022)

Low expression of ZHX1 and ZHX2 impacts on the prognosis of chronic lymphocytic leukemia
por: Maciel, Natália Ioseph Gladistone, et al.
Publicado: (2021)

Low expression of ZHX3 is associated with progression and poor prognosis in colorectal cancer
por: Cai, Zhai, et al.
Publicado: (2023)

Upregulation of ZHX2 predicts poor prognosis and is correlated with immune infiltration in gastric cancer
por: Cheng, Anqi, et al.
Publicado: (2021)

ZHX2 promotes HIF1α oncogenic signaling in triple-negative breast cancer
por: Fang, Wentong, et al.
Publicado: (2021)

ZHX1 Promotes the Proliferation, Migration and Invasion of Cholangiocarcinoma Cells
por: Kwon, Ryuk-Jun, et al.
Publicado: (2016)

USP13 promotes deubiquitination of ZHX2 and tumorigenesis in kidney cancer
por: Xie, Haibiao, et al.
Publicado: (2022)

BRCA1/2 Serves as a Biomarker for Poor Prognosis in Breast Carcinoma
por: Jin, Tong Yi, et al.
Publicado: (2022)

CDCA5 promotes the progression of breast cancer and serves as a potential prognostic biomarker
por: Hu, Hao, et al.
Publicado: (2022)

ZHX2 is a repressor of α-fetoprotein expression in human hepatoma cell lines
por: Shen, H, et al.
Publicado: (2008)

Transcription factor Zhx2 restricts NK cell maturation and suppresses their antitumor immunity
por: Tan, Siyu, et al.
Publicado: (2021)

ZHX2 inhibits thyroid cancer metastasis through transcriptional inhibition of S100A14
por: Zhang, Yankun, et al.
Publicado: (2022)

Zhx2 maintains islet β-cell mass and function by transcriptionally regulating Pax6
por: Ding, Lu, et al.
Publicado: (2023)

ZHX1 Inhibits Gastric Cancer Cell Growth through Inducing Cell-Cycle Arrest and Apoptosis
por: Ma, Xingjie, et al.
Publicado: (2016)

PROZ May Serve as a Prognostic Biomarker for Early Hepatocellular Carcinoma
por: Jiang, Xiaocong, et al.
Publicado: (2021)

SCUBE3 serves as an independent poor prognostic factor in breast cancer
por: Huo, Qin, et al.
Publicado: (2021)

GNPNAT1 promotes the stemness of breast cancer and serves as a potential prognostic biomarker
por: Hu, Hao, et al.
Publicado: (2023)

ZHX2 emerges as a negative regulator of mitochondrial oxidative phosphorylation during acute liver injury
por: Zhang, Yankun, et al.
Publicado: (2023)

ARL9 is upregulated and serves as a biomarker for a poor prognosis in colon adenocarcinoma
por: Yang, Hai-deng, et al.
Publicado: (2023)

ZHX2 deficiency enriches hybrid MET cells through regulating E-cadherin expression
por: He, Yan, et al.
Publicado: (2023)

Tumor suppressor ZHX2 inhibits NAFLD–HCC progression via blocking LPL-mediated lipid uptake
por: Wu, Zhuanchang, et al.
Publicado: (2019)

SKA1/2/3 serves as a biomarker for poor prognosis in human lung adenocarcinoma
por: Chen, Cheng, et al.
Publicado: (2020)

ZHX3 promotes the progression of urothelial carcinoma of the bladder via repressing of RGS2 and is a novel substrate of TRIM21
por: Deng, Minhua, et al.
Publicado: (2021)

Transketolase Serves as a Biomarker for Poor Prognosis in Human Lung Adenocarcinoma
por: Niu, Cong, et al.
Publicado: (2022)

Loss of the transcription repressor ZHX3 induces senescence-associated gene expression and mitochondrial-nucleolar activation
por: Igata, Tomoka, et al.
Publicado: (2022)

COL11A1 serves as a biomarker for poor prognosis and correlates with immune infiltration in breast cancer
por: Luo, Qi, et al.
Publicado: (2022)

ZHX2 enhances the cytotoxicity of chemotherapeutic drugs in liver tumor cells by repressing MDR1 via interfering with NF-YA
por: Ma, Hongxin, et al.
Publicado: (2014)

Long Noncoding RNA Serve as a Potential Predictive Biomarker for Breast Cancer: A Meta-Analysis
por: Jiang, Xuefeng, et al.
Publicado: (2020)

miR-29a-3p represses proliferation and metastasis of gastric cancer cells via attenuating HAS3 levels
por: Bai, Feihu, et al.
Publicado: (2018)

FAM72 serves as a biomarker of poor prognosis in human lung adenocarcinoma
por: Yu, Yilin, et al.
Publicado: (2021)

Cooperative regulation of Zhx1 and hnRNPA1 drives the cardiac progenitor-specific transcriptional activation during cardiomyocyte differentiation
por: Chen, Yang, et al.
Publicado: (2023)

Novel structural features in two ZHX homeodomains derived from a systematic study of single and multiple domains
por: Bird, Louise E, et al.
Publicado: (2010)

Cytochrome b561 Serves as a Potential Prognostic Biomarker and Target for Breast Cancer
por: Yang, Xiaochen, et al.
Publicado: (2021)

HCK can serve as novel prognostic biomarker and therapeutic target for Breast Cancer patients
por: Zhu, Xudong, et al.
Publicado: (2020)

Long Noncoding RNAs Serve as Potential Diagnostic Biomarkers for Colorectal Cancer
por: Cai, Juan, et al.
Publicado: (2019)

A kinase‐interacting protein 1 may serve as a potential biomarker for deteriorative tumor features and poor prognosis in gastric cancer patients
por: Lin, Rongbo, et al.
Publicado: (2020)

Dysregulated microRNA expression profiles in gastric cancer cells with high peritoneal metastatic potential
por: Feng, Yaning, et al.
Publicado: (2018)

ZHX2 mediates proteasome inhibitor resistance via regulating nuclear translocation of NF‐κB in multiple myeloma
por: Jiang, Jifeng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l9k5diqs4b3h45i2q1kjnlaea2